Confirm changes
Please review and confirm your changes below.Optional but important : get this fund Verified !
If you are an employee of the fund, add your professional email address below and get the Verified checkmark.
Only employees of a verified fund can change its informations.
Your email address will be used for verification purposes only
Are you an employee of this fund ?
Add your professional email address below for verification
Overview
| Who we are | N/A |
| Value add | N/A |
| Firm type | Corporate VC |
| Global HQ | USA |
| Branch office #1 | |
| Branch office #2 | |
| Branch office #3 | |
| Branch office #4 | |
| Branch office #5 |
Thesis
| Funding requirements | We invest in start-up companies developing medical device and diagnostic products that address major diseases and conditions prevalent in industrialized countries as the population ages (such as cancer, cardiovascular and neurological diseases, orthopedic problems, respiratory conditions, and gastrointestinal disorders). In these areas, we favor companies with novel, single-use medical devices that can provide clinically efficacious therapy, at lower cost, and with manageable and acceptable regulatory and reimbursement risks. We look for start-up ventures featuring product concepts that can be advanced with minimal infrastructure and head-count – companies that can demonstrate clinical efficacy of their product or technology early on, and thus create strong potential for partnerships and acquisitions. Synergy also assists our portfolio companies in developing corporate partnerships in Japan at the appropriate time, which can also provide significant strategic and economic benefits. Our LPs are major Japan medical device corporations. |
| Funding stages | 3. Early Revenue |
| Lead | N/A |
| Check size | $250k to $1M |
| Target countries |  USA |
Settings
| How to get in touch | Intro preferred |
| Default email or URL to receive deal flow | |
| CRM | |
| Website | http://www.synergyventures.net/ |
Do you fit this investor's criteria ?
We invest in start-up companies developing medical device and diagnostic products that address major diseases and conditions prevalent in industrialized countries as the population ages (such as cancer, cardiovascular and neurological diseases, orthopedic problems, respiratory conditions, and gastrointestinal disorders). In these areas, we favor companies with novel, single-use medical devices that can provide clinically efficacious therapy, at lower cost, and with manageable and acceptable regulatory and reimbursement risks. We look for start-up ventures featuring product concepts that can be advanced with minimal infrastructure and head-count – companies that can demonstrate clinical efficacy of their product or technology early on, and thus create strong potential for partnerships and acquisitions. Synergy also assists our portfolio companies in developing corporate partnerships in Japan at the appropriate time, which can also provide significant strategic and economic benefits. Our LPs are major Japan medical device corporations.